Local News SEngine Precision Medicine and Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment for Aggressive and Untreatable TumorsBusiness Wire | February 11, 2022SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs on patient-derived…dcorriganFebruary 11, 2022 Read More
Local News How Does Leukemia Escape from Immunotherapy?Fred Hutch | February 10, 2022When an experimental new cancer treatment shows promising results for many patients, these successes are…dcorriganFebruary 10, 2022 Read More
Local News The Paul G. Allen Frontiers Group Announces 23 New Allen Distinguished InvestigatorsAllen Institute | February 10, 2022Charting millions of unknown neurons in the octopus arm. Coaxing engineered mini-organs to grow their…dcorriganFebruary 10, 2022 Read More
Local News The Brain-Gut Connection: Dr. Person’s Unique Expertise Addresses Children with Chronic Gastrointestinal IssuesSeattle Children's | February 8, 2022Seattle Children’s is excited to welcome Dr. Hannibal Person to the Gastroenterology and Hepatology team.…dcorriganFebruary 8, 2022 Read More
Local News Coronavirus’ Distant Past Reveals Ancient Roots of Trait That Could Help Them Jump SpeciesFred Hutch | February 7, 2022To infect our cells, SARS-CoV-2’s spike protein turns the key on the molecular doorway formed…dcorriganFebruary 7, 2022 Read More
Local News Seattle Children’s Welcomes Dr. Mignon Loh to Lead Cancer and Blood Disorders Care and ResearchSeattle Children's | February 4, 2022Last year, if you had told Dr. Mignon Loh that she would soon become the leader of…dcorriganFebruary 4, 2022 Read More
Local News ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin LymphomaSeagen | February 4, 2022Seagen announced that the Phase III ECHELON-1 clinical trial demonstrated a statistically significant improvement in…dcorriganFebruary 4, 2022 Read More
Local News Liver Institute Northwest Participating in RESPONSE, a Global Phase III Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)BioSpace | February 2, 2022Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study…dcorriganFebruary 2, 2022 Read More
Local News Promising Young Scientists: Moez DawoodBrotman Baty Institute | January 31, 2022Moez Dawood has numerous opportunities to explore saturation genome editing working alongside BBI’s Dr. Lea…dcorriganJanuary 31, 2022 Read More
Local News ‘Continuum of Expertise’ of International Researchers Examines Pediatric EpilepsyBrotman Baty Institute | January 31, 2022About 470,000 children in the United States are diagnosed with epilepsy, or 6.3 out of…dcorriganJanuary 31, 2022 Read More